Study 2018-53-02 (part two) (HTA) Immunoglobulins

Ongoing study - This part 2 of the HTA study (for part 1).  aims at describing the current use of Immunoglobulins in Belgium, as well as future trends. The goal is to draft recommendations on the most effective use and reimbursement of Immunoglobulins.

Published on: 
2019/09/06